Fig. 3From: Cost-effectiveness analysis of the prevention of mother-to-child transmission of HIVThe effects of changes in variables on the benefit–cost ratio. AIDS acquired immunodeficiency syndrome, ART antiretroviral therapy, GDP gross domestic product, HIV human immunodeficiency virus, PMTCT prevention of mother-to-child transmissionBack to article page